Vimarsana
Biggest News Aggregation in the World

John Krystal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Krystal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Krystal Today - Breaking & Trending Today

Quanta Magazine - Vimarsana News

Quanta Magazine

Drugs that target the neurotransmitter serotonin have long been prescribed to treat depression. Now the spotlight is turning to other aspects of brain chemistry. In this episode, the neuropharmacologist John Krystal shares findings that are overturning our understanding of depression.

An Omega-6 Fatty Acid Linked To Reduced Risk Of Bipolar Disorder: Study - Vimarsana News

An Omega-6 Fatty Acid Linked To Reduced Risk Of Bipolar Disorder: Study

The new study also indicates the possibility of using dietary intervention to prevent or slow down the progression of psychiatric disorders.

An omega-6 fatty acid may reduce the risk for - Vimarsana News

An omega-6 fatty acid may reduce the risk for

<p>A genetic propensity to higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry, and seafood, has been found to be linked with a lower risk for bipolar disorder, according to a new study in <em>Biological Psychiatry</em>, published by Elsevier. This new evidence paves the way for potential lifestyle or dietary interventions.</p> <p>&nbsp;</p>

Genetic propensity to higher arachidonic acid levels linked to lower bipolar disorder risk - Vimarsana News

Genetic propensity to higher arachidonic acid levels linked to lower bipolar disorder risk

A genetic propensity to higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry, and seafood, has been found to be linked with a lower risk for bipolar disorder, according to a new study in Biological Psychiatry, published by Elsevier.

Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression - Vimarsana News

Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression

/PRNewswire/ -- Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation...